BioVectra BioVectra is a biotech and pharmaceutical contract development and manufacturing organization (CDMO). | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ||
Founding Date | Founding Date 1970 | Founding Date 2014 | Founding Date 2016 | Founding Date 1990 |
Type | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Charlottetown, CA HQ | Locations San Francisco, US HQ Bozeman, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Ewing Township, US HQ |
Employees | Employees 607 | Employees 2216% increase | Employees 156% decrease | Employees 4 |
Funding | ||||
Latest funding round | Latest funding round $ 39.8m (over 4 years ago) | Latest funding round $ 15m (over 9 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 77.3m | Total funding raised $ 17.8m | Total funding raised $ 17m | Total funding raised N/A |

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyCellOxess is a company that provides healthcare and biotechnology services.
View company